Pharmaceutical Business review

Amnis and Gene Company sign marketing agreement

Effective immediately, the scientific research communities in Hong Kong, Shanghai, Beijing and Guangzhou now have access to this important cell analysis technology.

Cheung To, chairman of Gene Company, said: “We envisage that distribution of the Amnis ImageStream system will remarkably empower pioneering labs with next generation microscopy and flow cytometry in a single platform to advance applications in drug discovery, molecular and cellular research and diagnostics in China. Gene Company has high confidence in Amnis and looks forward to a synergetic cooperation.”